15 September 2025: 'I got a fertility test done at 29. My plans have completely changed.'
Anti-Müllerian Hormone (AMH) testing helps women understand ovarian reserve, but results can be complex. Dr Simon Nothman explains how expert guidance ensures informed fertility decisions without unnecessary alarm.
Anti-Müllerian Hormone (AMH) testing has become a popular way for women to assess their fertility, but results can be complex to interpret. In a feature on Mamamia, Dr Simon Nothman explains that while AMH indicates ovarian reserve, it does not reflect egg quality or guarantee pregnancy. With expert guidance, testing can empower women to make informed decisions about their reproductive health without unnecessary alarm.
Dr Simon Nothman
Dr Simon Nothman is a fertility and women’s health specialist dedicated to patient-centred care, combining advanced clinical expertise with a holistic approach to support each individual’s reproductive journey. Trained in Australia and Israel, he has extensive experience in infertility management, fertility preservation, and complex reproductive health conditions. Passionate about education, he also mentors the next generation of healthcare professionals.